Steric Effects on the Photovoltaic Performance of Panchromatic Ruthenium Sensitizers for Dye-Sensitized Solar Cells.

Three new heteroleptic Ru complexes, CYC-B22, CYC-B23C, and CYC-B23T, were prepared as sensitizers for coadsorbent-free, panchromatic, and efficient dye-sensitized solar cells. They are simultaneously functionalized with highly conjugated anchoring and ancillary ligands to explore the electronic and steric effects on their photovoltaic characteristics. The coadsorbent-free device based on CYC-B22 achieved the best power conversion efficiency (PCE) of 8.63% and a panchromatic response extending to 850 nm. The two stereoisomers, CYC-B23C and CYC-B23T coordinated with an unsymmetrical anchoring ligand, display similar absorption properties and the same driving forces for electron injection as well as dye regeneration. Nevertheless, the devices show not only the remarkably distinct PCE (6.64% vs 8.38%) but also discernible stability. The molecular simulation for the two stereoisomers adsorbed on TiO2 clarifies the distinguishable distances (16.9 Å vs 19.0 Å) between the sulfur atoms in the NCS ligands and the surface of the TiO2, dominating the charge recombination dynamics and iodine binding and therefore the PCE and stability of the devices. This study on the steric effects caused by the highly conjugated and unsymmetrical anchoring ligand on the adsorption geometry and photovoltaic performance of the dyes paves a new way for advancing the molecular design of polypyridyl metal complex sensitizers.

Common patterns in the public reporting of waiting time and waiting list information: Findings from a sample of OECD jurisdictions.

We present findings from a review of published literature and administrative documentation on waiting time and waiting list reporting models for elective treatment in a sample of international jurisdictions (a subset of OECD countries, with regional reporting regimes treated as distinct jurisdictions). In this paper we identified common patterns in the measurement and reporting of waiting time and waiting list information for elective treatment. We mapped the waiting time, waiting list, and key performance indicator statistics reported by 15 English-speaking international jurisdictions. Three distinct patterns of maximum waiting time target measures for elective treatment were identified amongst our international sample following our patient pathway event time-point analysis: (i) full-pathway maximum wait time targets; (ii) separate wait time targets for "time-to-diagnosis" and "time-to-treatment"; and (iii) "Time-to-Treatment" waiting time target only. Our review also revealed common patterns in the reporting of waiting time and waiting list statistics as well as KPI measures amongst a sub-sample of English-speaking jurisdictions. These common patterns provide a starting point towards more standardised measurement and reporting of waiting time and waiting list statistics in benchmarking access to elective care internationally.

Structural Engineering of Organic D-A-π-A Dyes Incorporated with a Dibutyl-Fluorene Moiety for High-Performance Dye-Sensitized Solar Cells.

Structural engineering of the light-harvesting dyes employed in DSSCs (dye-sensitized solar cells) with a systematic choice of the electron-donating and -accepting groups as well as the π-bridge allows the (photo)physical properties of dyes to match the criteria needed for improving the DSSC efficiency. Herein, we report an effective approach of molecular engineering of DSSC sensitizers, aiming to gain insights on the configurational impact of the fluorenyl unit on the optoelectronic properties and photovoltaic performance of DSSCs. Five new organic dyes (GZ116, GZ126, GZ129, MA1116, and MA1118) with a D-A-π-A framework integrated with a fluorenyl moiety were designed and synthesized for DSSCs. The fluorenyl unit is configured as part of the π-spacer for the GZ series, whereas it connected on the electron-deficient quinoxaline motif for the MA series. The devices fabricated from the MA1116 sensitizer produced the best performance under standard AM 1.5 G solar conditions as well as dim-light (300-6000 lx) illumination. The devices fabricated from MA1116 displayed a PCE of 8.68% (Jsc = 15.00 mA cm-2, Voc = 0.82 V, and FF = 0.71) under 1 sun and 26.81% (Jsc = 0.93 mA cm-2, Voc = 0.68 V, and FF = 0.76) under 6000 lx illumination. The device efficiency based on dye MA1116 under 1 sun outperformed that based on the standard N719 dye, whereas a comparable performance between devices based on MA1116 and N719 was achieved under dim-light conditions. A combination of enhancing the charge separation, suppressing dye aggregation, and providing better insulation that prevents the oxidized redox mediator from approaching the TiO2 surface all contribute to the superior performance of DSSCs fabricated based on these light-harvesting dyes. The judicious integration of the fluorenyl unit in a D-A-π-A-based DSSC would be a promising strategy to boost the device performance.

Synthesis, Luminescence, and Structure of a Polymorphic Polyfluorinated Diiodoplatinum(II) Diimine Complex.

PtI2(5,5'-bis(HCF2CH2OCH2)-2,2'-bpy)], 55-2FH-PtI2, is the first example of a substituted fluorinated diiodoplatinum diimine complex that exhibits polymorphism. The complex, upon recrystallization, forms two different polymorphs, denoted as α and ß forms. The luminescence of the α and ß forms are the same in glassy solution at 77 K; however, in the solid state, they differ significantly. The major difference between them lies in the solid-state packing of the crystalline structure. The α form is a square planar polyfluorinated PtI2-containing complex. Its extended herringbone structure consists of two neighboring stacked bipyridyl planes that do not overlap. The α form emits stronger than its parent molecule, [PtI2bpy], and much stronger than the ß polymorph. The ß form has a slight tetrahedral distortion about the metal center that ultimately changes the geometry of the complex and decreases the d-orbital splitting from square planar. Furthermore, overlapping bipyridine rings in the extended structure of the ß form quench the emission thus resulting in a lower energy emission. Additionally, the ß form shows only one type of C-H···O intermolecular stacking interaction that can cause the moderate distortion of the metal core.

Lipid-Wrapped Upconversion Nanoconstruct/Photosensitizer Complex for Near-Infrared Light-Mediated Photodynamic Therapy.

Photodynamic therapy (PDT) is a noninvasive medical technology that has been applied in cancer treatment where it is accessible by direct or endoscope-assisted light irradiation. To lower phototoxicity and increase tissue penetration depth of light, great effort has been focused on developing new sensitizers that can utilize red or near-infrared (NIR) light for the past decades. Lanthanide-doped upconversion nanoparticles (UCNPs) have a unique property to transduce NIR excitation light to UV-vis emission efficiently. This property allows some low-cost, low-toxicity, commercially available visible light sensitizers, which originally are not suitable for deep tissue PDT, to be activated by NIR light and have been reported extensively in the past few years. However, some issues still remain in the UCNP-assisted PDT platform such as colloidal stability, photosensitizer loading efficiency, and accessibility for targeting ligand installation, despite some advances in this direction. In this study, we designed a facile phospholipid-coated UCNP method to generate a highly colloidally stable nanoplatform that can effectively load a series of visible light sensitizers in the lipid layers. The loading stability and singlet oxygen generation efficiency of this sensitizer-loaded lipid-coated UCNP platform were investigated. We also have demonstrated the enhanced cellular uptake efficiency and tumor cell selectivity of this lipid-coated UCNP platform by changing the lipid dopant. On the basis of the evidence of our results, the lipid-complexed UCNP nanoparticles could serve as an effective photosensitizer carrier for NIR light-mediated PDT.

Student-led simulation: preparing students for leadership.

It is vital to prepare nurses to become informed leaders with the required knowledge and skills to support effective patient care and outcomes. This article describes an innovative teaching method that enables students to create simulation scenarios based on their clinical experiences, to lead simulations and to take part in self-reflection and peer review activities. The article shows how the method can help prepare nursing students to become future leaders by allowing them to practise 'real-life', real-time leadership skills, and apply theory to practice in the safety of a simulated scenario.

Ethical Issues in Social Media Research for Public Health.

Social media (SM) offer huge potential for public health research, serving as a vehicle for surveillance, delivery of health interventions, recruitment to trials, collection of data, and dissemination. However, the networked nature of the data means they are riddled with ethical challenges, and no clear consensus has emerged as to the ethical handling of such data. This article outlines the key ethical concerns for public health researchers using SM and discusses how these concerns might best be addressed. Key issues discussed include privacy; anonymity and confidentiality; authenticity; the rapidly changing SM environment; informed consent; recruitment, voluntary participation, and sampling; minimizing harm; and data security and management. Despite the obvious need, producing a set of prescriptive guidelines for researchers using SM is difficult because the field is evolving quickly. What is clear, however, is that the ethical issues connected to SM-related public health research are also growing. Most importantly, public health researchers must work within the ethical principles set out by the Declaration of Helsinki that protect individual users first and foremost.

Simulation using 'live' adult service users and moulage in a variety of settings.

This article shows how simulation can be modified and adapted to benefit higher education institutions (HEIs) in a variety of situations. These situations can involve the engagement of service users (SUs) and moulage, or application of make-up to simulate clinical presentations, to ensure skill enhancement, ultimately to support and empower students so they can achieve their potential. This article describes a unique collaboration between staff at an HEI and SUs, who have worked together in simulation activities. The development of simulation using SUs is at the heart of developing nursing student education and recruitment. It has created communities of practice working across traditional departmental boundaries to provide innovative learning opportunities for students. This collaboration links to the political imperative to improve education in the health and social care sector, highlights the integration of skills development into theory, focuses on person-centred care and demonstrates how the HEI produces a compassionate and caring workforce.

Structural Tuning of Anion-Templated Motifs with External Stimuli through Crystal-to-Crystal Transformation.

Protonation of trans-1,2-bis(4-pyridyl)ethylene (4,4'-bpe) with dilute sulfuric acid (33 %) afforded a protonated adduct [{4,4'-bpe⋅2 H+ }2 {HSO4 }-2 {SO4 }-2 {H2 O}2 ] (1). The neighboring olefinic bond in 1 is in a suitable range (3.931-4.064 Å) to undergo a photochemical [2+2] cycloaddition reaction. Upon irradiation with UV light (365 nm), 1 undergoes a molecular sliding involving the 4,4'-bpe⋅2 H+ units, affording 2, stabilized through OSO4 ⋅⋅⋅π interactions. Heating 1 to 50° C leads to a 3D hydrogen-bonded organic framework (HOF) (3). This process occurs through thermal dissociation of the bisulfate anion. Diffusion of iodine through the crystal lattice of 1 and 3 enables the reduction of sulfate to bisulfate, affording a 1D hydrogen-bonded chain (4). Solid-state 13 C CPMAS NMR, IR, DSC, and powder XRD studies further support stimuli-responsive structural tuning through crystal-to-crystal transformation. All these conversions occur with significant translational and rotational movements along with a series of bond-breaking and bond-forming processes.

Cross-Linked Fluorescent Supramolecular Nanoparticles as Finite Tattoo Pigments with Controllable Intradermal Retention Times.

Tattooing has been utilized by the medical community for precisely demarcating anatomic landmarks. This practice is especially important for identifying biopsy sites of nonmelanoma skin cancer (NMSC) due to the long interval (i.e., up to 3 months) between the initial diagnostic biopsy and surgical treatment. Commercially available tattoo pigments possess several issues, which include causing poor cosmesis, being mistaken for a melanocytic lesion, requiring additional removal procedures when no longer desired, and potentially inducing inflammatory responses. The ideal tattoo pigment for labeling of skin biopsy sites for NMSC requires (i) invisibility under ambient light, (ii) fluorescence under a selective light source, (iii) a finite intradermal retention time (ca. 3 months), and (iv) biocompatibility. Herein, we introduce cross-linked fluorescent supramolecular nanoparticles (c-FSNPs) as a "finite tattoo" pigment, with optimized photophysical properties and intradermal retention time to achieve successful in vivo finite tattooing. Fluorescent supramolecular nanoparticles encapsulate a fluorescent conjugated polymer, poly[5-methoxy-2-(3-sulfopropoxy)-1,4-phenylenevinylene] (MPS-PPV), into a core via a supramolecular synthetic approach. FSNPs which possess fluorescent properties superior to those of the free MPS-PPV are obtained through a combinatorial screening process. Covalent cross-linking of FSNPs results in micrometer-sized c-FSNPs, which exhibit a size-dependent intradermal retention. The 1456 nm sized c-FSNPs display an ideal intradermal retention time (ca. 3 months) for NMSC lesion labeling, as observed in an in vivo tattoo study. In addition, the c-FSNPs induce undetectable inflammatory responses after tattooing. We believe that the c-FSNPs can serve as a "finite tattoo" pigment to label potential malignant NMSC lesions.

Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.

BACKGROUND: Incidence of inflammatory bowel disease (IBD) is increasing in Asia, but population-based prevalence data are limited. This study examined IBD incidence and prevalence based on results of a territory-wide IBD registry in Hong Kong. METHODS: We collected data on 2575 patients with IBD (1541 ulcerative colitis [UC], 983 Crohn's disease [CD], 51 IBD unclassified) from 1981 to 2014 using hospital and territory-wide administrative coding system. Prevalence and incidence, disease phenotype, surgery, and mortality were analyzed. RESULTS: Adjusted prevalence of IBD, UC, CD, and IBD unclassified per 100,000 individuals in 2014 were 44.0, 24.5, 18.6, and 0.9, respectively. Age-adjusted incidence of IBD per 100,000 individuals increased from 0.10 (95% confidence interval, 0.06-0.16) in 1985 to 3.12 (95% confidence interval, 2.88-3.38) in 2014. UC:CD incidence ratio reduced from 8.9 to 1.0 over 30 years (P < 0.001). A family history of IBD was reported in 3.0% of patients. Stricturing or penetrating disease was found in 41% and perianal disease in 25% of patients with CD. 5-aminosalicylate use was common in UC (96%) and CD (89%). Cumulative rates of surgery for CD were 20.3% at 1 year and 25.7% at 5 years, and the corresponding rates for UC were 1.8% and 2.1%, respectively. Mortality for CD and UC was not significantly different from the general population. CONCLUSIONS: In a population-based study in Hong Kong, prevalence of IBD is lower than in the west although comparable to that of other East Asian countries. Complicated CD is common. Overall mortality remains low in Asians with IBD.

Structure-performance correlations of organic dyes with an electron-deficient diphenylquinoxaline moiety for dye-sensitized solar cells.

The high performances of dye-sensitized solar cells (DSSCs) based on seven new dyes are disclosed. Herein, the synthesis and electrochemical and photophysical properties of a series of intentionally designed dipolar organic dyes and their application in DSSCs are reported. The molecular structures of the seven organic dyes are composed of a triphenylamine group as an electron donor, a cyanoacrylic acid as an electron acceptor, and an electron-deficient diphenylquinoxaline moiety integrated in the π-conjugated spacer between the electron donor and acceptor moieties. The DSSCs based on the dye DJ104 gave the best overall cell performance of 8.06 %; the efficiency of the DSSC based on the standard N719 dye under the same experimental conditions was 8.82 %. The spectral coverage of incident photon-to-electron conversion efficiencies extends to the onset at the near-infrared region due to strong internal charge-transfer transition as well as the effect of electron-deficient diphenylquinoxaline to lower the energy gap in these organic dyes. A combined tetraphenyl segment as a hydrophobic barrier in these organic dyes effectively slows down the charge recombination from TiO2 to the electrolyte and boosts the photovoltage, comparable to their Ru(II) counterparts. Detailed spectroscopic studies have revealed the dye structure-cell performance correlations, to allow future design of efficient light-harvesting organic dyes.

Effects of electronic mixing in ruthenium(II) complexes with two equivalent acceptor ligands. spectroscopic, electrochemical, and computational studies.

The lowest energy metal to ligand charge transfer (MLCT) absorption bands found in ambient solutions of [Ru(NH(3))(4)(Y-py)(2)](2+) and [Ru(L)(2)(bpy)(2)](+) complexes (Y-py a pyridine ligand and (L)(n) a substituted acetonylacetonate, halide, am(m)ine, etc.) consist of two partly resolved absorption envelopes, MLCT(lo) and MLCT(hi). The lower energy absorption envelope, MLCT(lo), in these spectra has the larger amplitude for the bis-(Y-py) complexes, but the smaller amplitude for the bis-bpy the complexes. Time-dependent density functional theory (TD-DFT) approaches have been used to model 14 bis-bpy, three bis-(Y-py), and three mono-bpy complexes. The modeling indicates that the lowest unoccupied molecular orbital (LUMO) of each bis-(Y-py) complex corresponds to the antisymmetric combination of individual Y-py acceptor orbitals and that the transition involving the highest occupied molecular orbital (HOMO) and LUMO (HOMO-->LUMO) is the dominant contribution to MLCT(lo) in this class of complexes. The LUMO of each bis-bpy complex that contains a C(2) symmetry axis also corresponds largely to the antisymmetric combination of individual ligand acceptor orbitals, while the LUMOs are more complex when there is no C(2) axis; furthermore, the energy difference between the HOMO-->LUMO and HOMO-->LUMO+1 transitions is too small (<1000 cm(-1)) to resolve in the spectra of the bis-bpy complexes in ambient solutions. Relatively weak MLCT(lo) absorption contributions are found for all of the [Ru(L)(2)(bpy)(2)](m+) complexes examined, but they are experimentally best defined in the spectra of the (L)(2) = X-acac complexes. TD-DFT modeling of the HOMO-->LUMO transition of [Ru(L)(4)bpy](m+) complexes indicates that it is too weak to be detected and occurs at significantly lower energy (about 3000-5000 cm(-1)) than the observed MLCT absorptions. Since the chemical properties of MLCT excited states are generally correlated with the HOMO and/or LUMO properties of the complexes, such very weak HOMO-->LUMO transitions can complicate the use of spectroscopic information in their assessment. As an example, it is observed that the correlation lines between the absorption energy maxima and the differences in ground state oxidation and reduction potentials (DeltaE(1/2)) have much smaller slopes for the bis-bpy than the mono-bpy complexes. However, the observed MLCT(lo) and the calculated HOMO-->LUMO transitions of bis-bpy complexes correlate very similarly with DeltaE(1/2) and this indicates that it is the low energy and small amplitude component of the lowest energy MLCT absorption band that is most appropriately correlated with excited state chemistry, not the absorption maximum as is often assumed.

Tuning through-bond Fe(III)/Fe(II) coupling by solvent manipulation of a central ruthenium redox couple.

The relationships between the intervalence energy (E(IT)) and the free energy difference (DeltaG) that exists between the minima of redox isomers (Fe(II)-Ru(III)/Fe(III)-Ru(II)) for various heterobimetallic complexes [(R-Fcpy)Ru(NH(3))(5)](2+/3+) (R = H, ethyl, Br, actyl; Fcpy = (4-pyridyl)ferrocenyl; Ru(NH(3))(5) = pentaam(m)ineruthenium) were examined. The changes in DeltaG for the complexes in various solvents were due to the effects of both solvent donicity and the substituents. The intervalence energy versus DeltaG, DeltaG approximately FDeltaE(1/2) (DeltaE(1/2) = E(1/2)(Fe(III/II)) - E(1/2)(Ru(III/II))), plots for the complexes in various solvents suggest a nuclear reorganization energy (lambda) of approximately 6000 cm(-1) (Chen et al. Inorg. Chem. 2000, 39, 189). For [(R-Fcpy)Ru(NH(3))(5)](2+) and [(et-Fcpy)Ru(NH(3))(4)(py)](2+) (Ru(NH(3))(4) = trans-tetraam(m)ineruthenium; py = pyridine) in various solvents, the E(1/2)(Ru(III/II)) of rutheniumam(m)ine typically was less than the E(1/2)(Fe(III/II)) of the ferrocenyl moiety. However, the low-donicity solvents resulted in relatively large values of E(1/2)(Ru(III/II)) for [(et-Fcpy)Ru(NH(3))(4)(py)](2+/3+/4+). Under our unique solvent conditions, a dramatic end-to-end interaction was observed for the trimetal cation, [(et-Fcpy)(2)Ru(NH(3))(4)](4+), in which the [(et-Fcpy)(2)Ru(NH(3))(4)](4+) included a central trans-tetraam(m)ineruthenium(III) and a terminal Fe(II)/Fe(III) pair. In general, results of electrochemical studies of [(et-Fcpy)(2)Ru(NH(3))(4)](2+) indicated both solvent-tunable E(1/2)(Ru(III/II)) (1 e(-)) and solvent-insensitive E(1/2)(Fe(III/II)) (2 e(-)) redox centers. However, in nitriles, two E(1/2)(Fe(III/II)) peaks were found with DeltaE(1/2)(Fe(III/II) - Fe(III/II)) ranging between 83 and 108 mV at a terminal metal-to-metal distance of up to 15.6 A. Furthermore, the bridging dpi orbital of the ruthenium center mediated efficient end-to-end interaction between the combinations of the terminal Fe(II)-Fe(III)/Fe(III)-Fe(II) pair. To our knowledge, this is the first example of solvent-tunable end-to-end interactions in multimetal complexes.

Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice.

Ten days treatment with nicotine reduced insoluble amyloid A beta 1-40 and Alpha beta 1-42 peptides by 80% in the cortex of 9-month-old APPsw mice, which is more than that observed in 14.5-month-old mice following nicotine treatment for 5.5 months. A reduction in A beta associated with cerebral vessels was observed in addition to that deposited as parenchymal plaques after 5.5 months treatment. The diminution in A beta peptides observed was not accompanied by changes in brain alpha, beta or gamma secretase-like activities, NGF or BDNF protein expression measured in brain homogenates. A significant increase in sAPP was observed after nicotine treatment of SH-SY5Yneuroblastoma cells that could be blocked by the nicotinic antagonist mecamylamine. Attenuation of elevated [(125)I]-alpha bungarotoxin binding (alpha 7) in APPsw mice was observed after 5.5 months nicotine treatment. Both these observations suggest that the reduction in insoluble A beta by nicotine might be in part mediated via the alpha 7 nicotinic receptor. Further studies are required to identify potential mechanisms of the nicotine's amyloid-reducing effect.

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

Neuronal nicotinic receptor binding sites as well as mRNA levels encoding for subunits alpha4, beta2, and alpha7 were analysed in 3-mo-old transgenic mice generated with a neuronal overexpression of human acetylcholinesterase and in age-matched controls. The acetylcholinesterase transgenic mice display progressive cognitive impairment in spatial learning and memory. We here report a significantly increased [3H]epibatidine and [125I]alphabungarotoxin binding in the cortex and the caudate putamen of these mice. Quantitativein situ hybridization showed significant upregulation of mRNA corresponding to the nicotinic receptor subunits alpha4, beta2, and alpha7 in various brain regions in the transgenic mice compared to nontransgenic controls. Our results suggest that disruption of balanced cholinergic transmission by constitutive overexpression of acetylcholinesterase is accompanied by variable upregulation of several nicotinic receptor subtypes, in particular these associated with cholinergic terminals participating in compensatory response.

Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).

Alzheimer's disease neuropathology is characterised by beta-amyloid plaques and neurofibrillary tangles. Inhibition of beta-amyloid accumulation may be essential for effective therapy in Alzheimer's disease. In this study we have treated transgenic mice carrying the Swedish mutation of human amyloid precursor protein [Tg(Hu.APP695.K670N-M671L)2576], which develop brain beta-amyloid deposits, with nicotine in drinking fluid (200 microg/mL) from 9-14.5 months of age (5.5 months). A significant reduction in amyloid beta peptide 1-42 positive plaques by more than 80% (p < 0.03) was observed in the brains of nicotine treated compared to sucrose treated transgenic mice. In addition, there was a selective reduction in extractable amyloid beta peptides in nicotine treated mice; cortical insoluble 1-40 and 1-42 peptide levels were lower by 48 and 60%, respectively (p < 0.005), whilst there was no significant change in soluble 1-40 or 1-42 levels. The expression of glial fibrillary acidic protein was not affected by nicotine treatment. These results indicate that nicotine may effectively reduce amyloid beta peptide aggregation in brain and that nicotinic drug treatment may be a novel protective therapy in Alzheimer's disease.